Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Times Interest Earned (2024 - 2026)

Updated

Apimeds Pharmaceuticals US's (APUS) Times Interest Earned came in at -1.95 for Q2 2026, compared with -115.55 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Times Interest Earned (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Times Interest Earned at Apimeds Pharmaceuticals US was -5.14; for FY2025, it came in at -42.09.

  • In prior years, Apimeds Pharmaceuticals US's Times Interest Earned was -10.83 in FY2024 and -19.63 in FY2023.
  • The Q2 2026 figure stands as the highest quarterly Times Interest Earned in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - -1.95
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.95
Dec 31, 2025 -32.65
Sep 30, 2025 -292.69
Jun 30, 2025 -115.55
Mar 31, 2025 -9.58
Dec 31, 2024 -7.65
Sep 30, 2024 -9.19
Jun 30, 2024 -19.34
Mar 31, 2024 -10.10
API Access

Apimeds Pharmaceuticals US Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=APUS&period=max&api_key=YOUR_API_KEY